Why Anavex (AVXL) Is Down 50% Today: EMA Rejects Alzheimer’s Drug Progress

Anavex stock plunged 50% in premarket trading after European regulators issued a negative vote on its Alzheimer’s drug blarcamesine. source: https://tokenist.com/why-anavex-avxl-is-down-50-today-ema-rejects-alzheimers-drug-progress/?utm_source=rss&utm_medium=rss&utm_campaign=why-anavex-avxl-is-down-50-today-ema-rejects-alzheimers-drug-progress